Ascendis Pharma A/S at JPMorgan Healthcare Conference Transcript
Great. Good morning, everyone. My name is Jess Fye. I'm a biotech analyst at JPMorgan, and we're continuing the Healthcare Conference today with Ascendis. We're going to go straight from the presentation into a Q&A session. If you want to ask a question in the room, someone will bring you a mic. If you want to ask it through the portal, I can repeat it for you up here, or you can listen to me ask questions.
But really looking forward to hearing the updates today on the back of yesterday's press release. I think Tim is going to come up and do a forward-looking statement, and then we'll pass it over to Jan for the presentation.
/- -
Thanks, Jess. Before we begin, I'd like to remind you this presentation will contain forward-looking statements, and our actual results and events could differ materially from those in the forward-looking statements. For additional information concerning the factors that may cause actual results to differ
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
